论文信息 - Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial - 字舞流文

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

J. Tabernero | Y. Janjigian | L. Wyrwicz | C. Shih | J. Metges | S. Rha | E. Cutsem | K. Shitara | A. Kawazoe | P. Bhagia | S. Qin | Jianming Xu | P. Yanez | Kan Li | Hyun Cheol Chung | S. Lonardi | Yuxian Bai | M. Bilici | Li Shen | Y. Ostapenko